Qscan Group announces investment in Alpenglow Australia

Hamilton Locke has advised Qscan Group (a Quadrant Private Equity portfolio company) on its investment in Australian radiology group, Alpenglow Australia. Alpenglow is a leading radiology brand, with sixteen practice locations throughout regional NSW and QLD and it also operates a state of the art radiologist reporting “Hub” in the Sydney CBD (servicing Alpenglow’s network of clinics and several external clients).

Qscan Group is a leading provider of diagnostic imaging services in Australia operating Qscan Radiology Clinics, Berera Radiology, Universal Medical Imaging, North Coast Radiology Clinics, South East Radiology and Alpenglow Australia. The combined group now operates 69 clinical locations providing services to more than 1 million patients annually.

The team at Hamilton Locke was led by partner Gordon McCann and assisted by lawyer Sahar Rostabeik. Hamilton Locke have now advised the Qscan Group on five bolt acquisitions.

Commenting on the transaction, Gordon McCann said: “We are delighted to once again assist Quadrant Private Equity with Qscan’s national expansion. In what is an exciting period ahead for Qscan, there is no doubt that Alpenglow will be a fantastic addition to the group”.

About Hamilton Locke

Hamilton Locke specialises in solving complex client problems and working with clients and advisers to build long-term relationships and value. We believe in the relentless pursuit of success for our clients and that is why we have grown an organisation of energised people, propelled by class leading technology, who are freed up from bureaucracy and administration to really focus on doing what they do best – solving complex client problems.